The Healthcare sector has been one of the net winners so far this year. While its performance has not been as spectacular as that of the technology sector (QQQ), it still managed to beat the S&P 500. Using the Vanguard Health Care ETF (VHT) as a proxy, the healthcare sector has returned 5.5% on a YTD basis, which compares favorably against the 3.2% that the S&P 500 has returned over the same time frame.

While the entire healthcare sector has outperformed, there are some stock candidates that remain left behind. One such stock is Boston Scientific (BSX), which has posted a -13% return so far this year. I believe that BSX presents an attractive opportunity for growth at a reasonable price, and in this article, I evaluate what makes this stock a potentially good investment, so let’s get started!

READ FULL ARTICLE HERE